Stock overview
X4 Pharmaceuticals Inc.
Explore the company, reported ownership, price history, and available source evidence.
X4 Pharmaceuticals common stock after the one-for-thirty reverse stock split, traded as XFOR under this CUSIP since April 28, 2025. The company develops treatments for rare hematology diseases.
- Last close
- $2.98
- · XFOR
- Tracked holders
- 1 fund
- Latest available 13F per fund
XFOR · USD
Price
Close · Nov 18, 2026
- Range low
- $2.45
- Range high
- $4.67
- Observations
- 252
- Session date
- Nov 18, 2026
Nov 18, 2025–Nov 18, 2026. Regular market hours only. Historical prices are unadjusted; splits and other corporate actions can affect comparisons.
Investor Popularity
Rows are narrowed by movement, fund type, and position size.
| Fund | Move | Value | Weight |
|---|---|---|---|
| Renaissance Technologies largest tracked holder Q3 2026 · filed Nov 12, 2026 · SEC filing | +538% 26'Q3 | $335,020 | 0% |
SEC Forms 4/5
Insiders
Financials
Official-source analysis
AI Earnings Report
No published AI Earnings Report yet
We publish a cited AI Earnings Report after an eligible official earnings filing is accepted and passes validation.
Options market